₹4.95▲0.41%
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -12.43 % |
3 Month Return | -39.51 % |
1 Year Return | -66.55 % |
Market Stats | |
Previous Close | ₹4.93 |
Open | ₹5.02 |
Volume | 83.52K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹19.72Cr |
P/E Ratio | 35.21 |
PEG Ratio | 157.21 |
Market Cap | ₹19.72 Cr |
P/B Ratio | 5.75 |
EPS | 0 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
![]() | NA | ₹19.72 Cr | 44.87% | 0.70 | -₹1 Cr | ₹27 Cr |
![]() | NA | ₹107.89 Cr | 247.39% | 0.51 | ₹2 Cr | ₹75 Cr |
![]() | NA | ₹14.32 Cr | -0.68% | 0.51 | NA | ₹2 Cr |
![]() | NA | ₹88.47 Cr | 66.06% | 0.53 | ₹1 Cr | ₹107 Cr |
![]() | NA | ₹96.22 Cr | 351.91% | 0.87 | NA | NA |
Organisation | Vivanza Biosciences Ltd |
Headquarters | |
Industry | Trading |
E-voting on shares | Click here to vote |
Key events for Vivanza Biosciences Ltd
Vivanza Biosciences reported a 46.32% YoY decrease in topline, with revenue declining by 32.6% QoQ. The loss increased by 309.27% YoY and 305.83% QoQ. Operating income decreased by 3344.44% YoY and 153.39% QoQ. EPS for Q4 was ₹-0.1, down by 285.65% YoY.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 56.76% to 59.95% in Jun 2024 quarter
Promoter Holding Down
Promoters have decreased holdings from 43.24% to 40.05% in Jun 2024 quarter
Profit Down
Netprofit is down for the last 4 quarters, 0.49 Cr → -0.41 Cr (in ₹), with an average decrease of 120.5% per quarter
Revenue Fall
Revenue is down for the last 4 quarters, 9.24 Cr → 4.39 Cr (in ₹), with an average decrease of 21.5% per quarter
Price Dip
In the last 1 month, Vivanza Biosci. stock has moved down by -12.4%
Q'1 24 | Q/Q Change | |
---|---|---|
Revenue | ₹4.42Cr | ↓32.62% |
Net Income | -₹0.41Cr | ↓295.24% |
Net Profit Margin | -9.28% | ↓390.00% |
2024 | Y/Y Change | |
---|---|---|
Revenue | ₹27.84Cr | ↑56.32% |
Net Income | ₹0.55Cr | ↓8.33% |
Net Profit Margin | 1.98% | ↓41.25% |
2024 | Y/Y Change | |
---|---|---|
Total Assets | ₹16.86Cr | ↓17.47% |
Total Liabilities | ₹12.14Cr | ↓24.27% |
2024 | Y/Y Change | |
---|---|---|
Operating Cash Flow | ₹1.78Cr | ↑1,012.50% |
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 40.05% | ||
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 59.95% | 5.63 | |
Others | 0% | 0.00 |
Vivanza Biosciences Ltd in the last 5 years
Lowest (-15423.93x)
December 21, 2022
Today (35.21x)
July 23, 2024
Industry (102.57x)
July 23, 2024
Highest (884.71x)
July 19, 2023
Vivanza Biosciences Ltd’s net profit fell -310% since last year same period to ₹0.41Cr in the Q4 2023-2024. On a quarterly growth basis, Vivanza Biosciences Ltd has generated -295.24% fall in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Vivanza Biosciences Ltd is currently in a Bearish trading position according to technical analysis indicators.
Vivanza Biosciences Ltd (530057) share price today is ₹4.95
Vivanza Biosciences Ltd is not listed on NSE
Vivanza Biosciences Ltd is listed on BSE
PE Ratio of Vivanza Biosciences Ltd is 35.21
PE ratio = Vivanza Biosciences Ltd Market price per share / Vivanza Biosciences Ltd Earnings per share
Today’s traded volume of Vivanza Biosciences Ltd(530057) is 83.52K.
Today’s market capitalisation of Vivanza Biosciences Ltd(530057) is ₹19.72Cr.
Vivanza Biosciences Ltd(530057 | Price |
---|---|
52 Week High | ₹14.74 |
52 Week Low | ₹4.68 |
Vivanza Biosciences Ltd(530057) share price is ₹4.95. It is down -66.42% from its 52 Week High price of ₹14.74
Vivanza Biosciences Ltd(530057) share price is ₹4.95. It is up 5.77% from its 52 Week Low price of ₹4.68
Vivanza Biosciences Ltd(530057 | Returns |
---|---|
1 Day Returns | 0.02% |
1 Month Returns | -12.43% |
3 Month Returns | -39.51% |
1 Year Returns | -66.55% |